Vivodyne (Series A)
Funding Details
- Awarder
- RSS - feeds.feedburner.com
- Date Award
- May 30, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Traction
- Already used by most top pharma companies, Vivodyne's platform significantly reduces trial risk and accelerates drug discovery.
- Company Description
- Vivodyne is rendering inaccurate animal testing obsolete, using automated robotic platforms and AI to grow and analyze thousands of fully functional human tissues. The company provides unprecedented, clinically relevant human data at massive scale, significantly reducing trial risk and accelerating drug discovery.
- Market
- Pharmaceuticals
- Location
- San Francisco, California, USA
- Coinvestors
- Lingotto Investment Management, Helena Capital, Fortius Ventures, Kairos Ventures, CS Ventures, Bison Ventures, MBX Capital